Recombinant Human RNF126 Protein，His

RNF126 is an E3 ubiquitin ligase that plays a significant role in various cellular processes, including protein degradation, cell cycle regulation, and DNA damage response. Its importance in tumor biology has garnered attention, as altered expression of RNF126 has been implicated in several types of cancers, suggesting it may serve as a potential biomarker or therapeutic target. Research has shown that RNF126 can regulate the stability of multiple substrates, influencing pathways critical for cell proliferation and survival. Moreover, its involvement in the modulation of the NF-kB signaling pathway, known for its role in inflammation and cancer progression, highlights its dual function in normal physiology and disease. Given these roles, the production of recombinant RNF126 protein is essential for studying its biochemical properties and understanding the underlying mechanisms of its action. By utilizing techniques such as protein purification and functional assays, researchers aim to elucidate the precise molecular interactions and pathways in which RNF126 is involved. This understanding could pave the way for developing strategies aimed at manipulating RNF126's function for therapeutic purposes, contributing to more effective cancer treatments and improved patient outcomes. The study of RNF126, therefore, not only provides insights into fundamental biological processes but also holds potential for advancements in targeted cancer therapies.